Download presentation
Presentation is loading. Please wait.
Published byFarida Sutedja Modified over 6 years ago
1
High neutrophil-to-lymphocyte ratio before starting anti-programmed cell death 1 immunotherapy predicts poor outcome in patients with metastatic melanoma Margaux Garnier, MD, Julia Zaragoza, MD, Nathalie Bénéton, MD, Guido Bens, MD, Victoire Meurisse, MD, Mahtab Samimi, MD, PhD, Hervé Maillard, MD, Laurent Machet, MD, PhD Journal of the American Academy of Dermatology Volume 79, Issue 1, Pages e2 (July 2018) DOI: /j.jaad Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions
2
Supplemental Fig 1 Kaplan–Meier curves for progression-free survival (A) and overall survival (B) by drug used (nivolumab or pembrolizumab). Journal of the American Academy of Dermatology , e2DOI: ( /j.jaad ) Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions
3
Supplemental Fig 2 Kaplan–Meier curves for progression-free survival (A) and overall survival (B) by NLR. NLR, Neutrophil-to-lymphocyte ratio; PD1, programmed cell death 1. Journal of the American Academy of Dermatology , e2DOI: ( /j.jaad ) Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com Inc.
All rights reserved.